TNF, tumor necrosis factor, 7124

N. diseases: 2724; N. variants: 31
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Kaempferol reduced CD3<sup>+</sup> T cell infiltration and gene expression of major proinflammatory cytokines, including interleukin (IL)-6, IL-17A and tumor necrosis factor (TNF)-α, in the psoriatic skin lesion. 31407330 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE The purpose of this study was to investigate the anti-atopic effects of UMB on 2,4-dinitrochlorobenzene (DNCB)- and house dust mite extract (Dermatophagoides farinae extract, DFE)-treated mice with AD-like skin lesions and on tumor necrosis factor (TNF)-α/interferon (IFN)-γ-treated HaCaT cells. 31437788 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Expression of TNF-α in palmoplantar pustulosis increased after anti-TNF-α therapy in the two examined patients with exacerbated skin lesions. 29611085 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The mRNA and protein expression levels in human and mouse skin lesions and TNF‑α‑stimulated HaCaT cells were detected using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting, and compared with the control groups. 31017270 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE In addition, Cal/BDP significantly suppressed the interleukin (IL)-23/IL-17-producing T (T17) pathogenic axis, including expression of IL-17a, IL-23a, IL-22 and TNF-α mRNA in skin lesions and expansion of CCR6<sup>+</sup> γδ T17 cells in the draining lymph nodes. 31705000 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE It was found that genistein can significantly improve IMQ-induced pathological scores of cutaneous skin lesions in mice, reduce epidermal thickness, and inhibit the expression of inflammatory factors,including interleukin (IL)-1β, IL-6, tumour necrosis factor-alpha (TNF-α), chemokine ligand 2 (CCL2), IL-17 and IL-23. 30743203 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Moreover, C5aR1 deficiency significantly decreased IMQ-induced infiltration of plasmacytoid dendritic cells (pDCs), monocytes and neutrophils in psoriatic skin lesions and functions of pDCs, evidenced by the remarkable reduction in the IMQ-induced production of interferon-α (IFN-α) and tumor necrosis factor α (TNF-α), and FMS-like tyrosine kinase 3 ligand (FLT3L)-dependent pDCs differentiation. 31447855 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Tumor necrosis factor inhibitors decrease the risk of cardiovascular events in moderate to severe psoriasis, but the association between their effects on endothelial function and those on skin lesions has not been well studied. 30168849 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE High concentrations of tumor necrosis factor-alpha (TNFα) are found in the skin lesions and plasma of patients with psoriasis. 28272075 2019
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The following were assessed: dermatitis severity scores; ear and dorsal skin haematoxylin and eosin staining; interleukin (IL)- 1α, IL-1β, IL-2, IL-4, IL-6, and tumour necrosis factor (TNF)-α cytokine levels in the serum; spleen index; spleen CD4 + /CD8 + T lymphocyte ratio; and phosphorylation levels of mitogen-activated protein kinases (MAPKs- p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK)), IκB-α, and nuclear factor (NF)-κB (p65) in skin lesions. 29698775 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE We first found that IL-1β and TNF-α mRNA expression was significantly decreased in the skin lesions treated with DDH-1. 30503675 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE Macroscopic and microscopic evaluation of skin lesions was performed together with measurements of serum levels of interleukin (IL)-1β, IL-6, tumour necrosis factor alpha (TNF-α), IL-17, IL-22, IL-10 and IL-4. 29409331 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE CRT effectively mitigated the secretion of pro‑inflammatory cytokines, including tumor necrosis factor‑α and interleukin 1β, as well as immune cell infiltration into skin lesions in a mouse model of AD‑like skin disease induced by dinitrochlorobenzene. 29845271 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE SP treatment significantly reduced the infiltration of mast cells and CD3-positive T cells as well as inflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and thymic stromal lymphopoietin (TSLP), in AD-like skin lesions and decreased the levels of IgE and thymus and activation-regulated chemokine in serum. 28833499 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE In the present study, the anti‑AD effects of a 70% ethanol extract of TAEE were investigated in 2,4‑dinitrochlorobenzene (DNCB)‑treated mice with AD‑like skin lesions and in tumor necrosis factor (TNF)‑α‑ and interferon (IFN)‑γ‑stimulated human keratinocytes (HaCaT cells). 30066901 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The mRNA expression in blood and skin lesion for TNF, IFN-γ, IL-1β, IL-6, and IL-17A significantly reduced in patients with ENL after treatment, while mRNA expression for IL-10 and TGF-β was significantly increased both in blood and skin lesion after treatment. 29479352 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE The expression levels of PGRN and TNF-α were elevated in LSc skin lesions compared with healthy control skin. 30268392 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE ASC-exosomes also significantly reduced mRNA expression of various inflammatory cytokines such as interleukin (IL)-4, IL-23, IL-31, and tumor necrosis factor-α (TNF-α) in AD skin lesions of Nc/Nga mice. 29996938 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE BS significantly reduced the protein and mRNA expression of TSLP, IL-6, and tumor necrosis factor-α in the AD skin lesions. 29455734 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 AlteredExpression group BEFREE Assessment of the concentration of the proinflammatory cytokines (IL-12, IL-23, IL-17 and TNF-α) in blood serum and their correlation with the intensity of skin lesions, the presence of psoriatic arthritis and the risk of development of obesity and metabolic syndrome. 30206447 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics. 29143979 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE We analyzed the presence of M4 macrophage markers (CD68, MRP8, MMP7, IL-6, and TNF-α) in 33 leprosy skin lesion samples from 18 patients with tuberculoid leprosy and 15 with lepromatous leprosy by immunohistochemistry. 30442123 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE We previously identified 6-sulfo LacNAc-expressing monocytes (slanMo) as TNF-α- and IL-23-producing cells in psoriatic skin lesions and as inducers of IFN-γ-, IL-17-, and IL-22-producing T cells. 29977237 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE CCL27 may act early in the course of disease, via the circulation, whereas TNF-α acts throughout the course of disease, in skin lesions. 29713456 2018
CUI: C0037284
Disease: Skin lesion
Skin lesion
0.100 Biomarker group BEFREE Ethanolic Extracts of <i>Artemisia apiacea</i> Hance Improved Atopic Dermatitis-Like Skin Lesions In Vivo and Suppressed TNF-Alpha/IFN-Gamma⁻Induced Proinflammatory Chemokine Production In Vitro. 29932162 2018